![]() |
市场调查报告书
商品编码
1368677
生理食盐水市场规模 - 药物类型(生理食盐水、低渗透压)、包装类型(软袋、塑胶瓶)、应用(慢性病、急性健康状况)、最终用户、全球预测 2023 - 2032Physiological Saline Market Size - Drug Type (Normal Saline, Hypotonic), Packaging Type (Flexible Bag, Plastic Bottle), Application (Chronic Disease, Acute Health Conditions), End-user, Global Forecast 2023 - 2032 |
2023 年至 2032 年间,全球生理食盐水市场复合年增长率将达到 6.2%。它仍然是医疗保健的重要组成部分,对于静脉输液、伤口清洁和诊断程序至关重要。此外,慢性病和外科手术的盛行率不断上升,导致对盐溶液的需求增加。
例如,根据世界卫生组织 2023 年 9 月的统计数据,非传染性疾病 (NCD) 每年夺走 4,100 万人的生命,占全球总死亡率的 74%。此外,每年有 1700 万人在 70 岁之前死于非传染性疾病,凸显了这些疾病对过早死亡的重大影响。此外,COVID-19 大流行凸显了其在呼吸护理方面的用途。随着患者健康意识的增强,人们对天然和安全产品的偏好日益增强,增加了对生理食盐水的需求。这些因素共同推动生理食盐水市场前景。
整个生理食盐水市场根据应用、最终用户和地区进行分类。
2023年至2032年,慢性病领域将经历重大发展。这种无菌且平衡的盐溶液在糖尿病、肾臟病和心血管问题等各种慢性健康状况的治疗和管理中发挥关键作用。随着全球慢性病负担持续加重,生理食盐水市场需求依然强劲,成为医疗保健中不可或缺的一部分。
门诊手术中心部分从 2023 年到 2032 年将实现值得称讚的复合年增长率。这些设施专注于门诊手术,依赖盐水溶液进行各种医疗应用,包括术前水合、伤口冲洗和术后护理。随着 ASC 趋势持续成长,生理食盐水市场份额仍然强劲,支持其在这些环境中提供安全有效的医疗保健方面发挥关键作用。
欧洲生理食盐水市场从 2023 年到 2032 年将呈现可观的复合年增长率。随着慢性病盛行率的上升,欧洲大陆的人口老化加剧了医疗保健环境中对生理食盐水解决方案的需求。例如,根据欧盟统计局的一份报告,基于年龄的预测表明,到2050 年,欧盟27 国预计将有近50 万百岁老人。欧洲的高医疗保健标准与严格的安全法规相结合,强调了这一重要性。生理食盐水。随着医疗实践的不断发展,欧洲医疗保健领域对这种基本医疗产品的需求仍然强劲。
Global Physiological Saline Market will witness 6.2% CAGR between 2023 and 2032. it remains a crucial component in healthcare, essential for intravenous fluids, wound cleansing, and diagnostic procedures. In addition, the rising prevalence of chronic diseases and surgical interventions contributes to increased demand for saline solutions.
For instance, according to September 2023 stats from WHO, noncommunicable diseases (NCDs) claim the lives of 41 million individuals annually, accounting for 74% of the total global mortality. Furthermore, each year, 17 million people succumb to NCDs before reaching the age of 70, underscoring the significant impact of these diseases on premature mortality. Furthermore, the COVID-19 pandemic highlighted its use for respiratory care. As patients become more health-conscious, there's a growing preference for natural and safe products, boosting the demand for physiological saline solutions. These factors collectively propel the physiological saline market outlook.
The overall Physiological Saline Market is classified based on application, end-user, and region.
The chronic diseases segment will undergo significant development from 2023 to 2032. This sterile and balanced salt solution plays a pivotal role in the treatment and management of various chronic health conditions, such as diabetes, kidney disease, and cardiovascular issues. As the global burden of chronic diseases continues to rise, the physiological saline market demand remains robust, making it an indispensable component in healthcare.
The ambulatory surgical centers segment will register a commendable CAGR from 2023 to 2032. These facilities, focused on outpatient procedures, rely on saline solutions for various medical applications, including pre-operative hydration, wound irrigation, and post-operative care. As the trend toward ASCs continues to grow, the physiological saline market share remains strong, supporting its crucial role in providing safe and effective healthcare in these settings.
Europe physiological saline market will showcase an appreciable CAGR from 2023 to 2032. The continent's aging population, in line with a rising prevalence of chronic diseases, fuels the need for saline solutions in healthcare settings. For instance, according to a report from Eurostat, an age-based projection indicates that the EU-27 is expected to have nearly 500,000 centenarians by the year 2050. The high healthcare standards in Europe, in tandem with stringent safety regulations, emphasize the significance of physiological saline. As medical practices continue to evolve, the demand for this essential medical product remains robust in the European healthcare landscape.